Patents Assigned to Acrux DDS PTY LTD
-
Patent number: 10449343Abstract: This invention relates to a device, a system and a method for applying a volume of liquid to a treatment surface. The device includes a container for containing the liquid, a pump for extracting liquid from the container, an actuator for operating the pump, and a collapsible receptacle for accommodating extracted liquid.Type: GrantFiled: November 25, 2014Date of Patent: October 22, 2019Assignee: ACRUX DDS PTY LTDInventors: Shu Kuen Chang, Alain Regard, Anastasios G Karahalios, Mark LaFever
-
Publication number: 20170157378Abstract: This invention relates to a device, a system and a method for applying a volume of liquid to a treatment surface. The device includes a container for containing the liquid, a pump for extracting liquid from the container, an actuator for operating the pump, and a collapsible receptacle for accommodating extracted liquid.Type: ApplicationFiled: November 25, 2014Publication date: June 8, 2017Applicant: ACRUX DDS PTY LTDInventors: Shu Kuen Chang, Alain Regard, Anastasios G. Karahalios, Mark LaFever
-
Publication number: 20160303359Abstract: An implement for applying a volume of liquid to a treatment surface includes a support onto which is mounted a receptacle. The receptacle defines a reservoir space which receives the liquid. The receptacle includes a wall having a working surface that is used to spread the liquid over the treatment surface. The wall is resiliently deformable such that in use the working surface maintains contact with the treatment surface when spreading the liquid. The implement is used in applying a transdermal lotion to the axilla area of a user. A system for transdermal administration of a physiological active agent from a liquid composition and a method of conducting the same are also provided.Type: ApplicationFiled: February 18, 2016Publication date: October 20, 2016Applicant: Acrux DDS Pty LtdInventors: Peter BAYLY, Mark Simon Bayly, Magnus Ahlstrom, Adam Charles Watkinson
-
Publication number: 20160250227Abstract: The invention is directed to a transdermal drug delivery composition which includes at least one physiologically active agent; and at least one volatile solvent; and at least one viscosity modulating agent. The invention extends to methods of administering such a composition to a subject and treatment of subjects using the composition.Type: ApplicationFiled: October 6, 2015Publication date: September 1, 2016Applicant: Acrux DDS Pty LtdInventors: Tony DIPIETRO, Andrew HUMBERSTONE, Igor GONDA, Adam WATKINSON, Kerrie SETIAWAN, Nina WILKINS
-
Patent number: 9289586Abstract: An implement for applying a volume of liquid to a treatment surface includes a support onto which is mounted a receptacle. The receptacle defines a reservoir space which receives the liquid. The receptacle includes a wall having a working surface that is used to spread the liquid over the treatment surface. The wall is resiliently deformable such that in use the working surface maintains contact with the treatment surface when spreading the liquid. The implement is used in applying a transdermal lotion to the axilla area of a user. A system for transdermal administration of a physiological active agent from a liquid composition and a method of conducting the same are also provided.Type: GrantFiled: June 27, 2014Date of Patent: March 22, 2016Assignee: ACRUX DDS PTY LTDInventors: Peter Bayly, Mark Simon Bayly, Magnus Ahlstrom, Adam Charles Watkinson
-
Patent number: 9180194Abstract: The invention is directed to a transdermal drug delivery composition which includes at least one physiologically active agent; and at least one volatile solvent; and at least one viscosity modulating agent. The invention extends to methods of administering such a composition to a subject and treatment of subjects using the composition.Type: GrantFiled: October 8, 2014Date of Patent: November 10, 2015Assignee: ACRUX DDS PTY LTDInventors: Tony Dipietro, Andrew Humberstone, Igor Gonda, Adam Watkinson, Kerrie Setiawan, Nina Wilkins
-
Patent number: 9078810Abstract: A transdermal delivery system comprising a composition comprising a physiologically active agent and a penetration enhancer wherein the penetration enhancer comprises a combination of (i) an ester of salicylic acid, preferably selected from the C6 to C30 aliphatic ester of salicylic acid and (ii) polyethylene glycol (PEG) of average molecular weight no more than 300.Type: GrantFiled: May 6, 2013Date of Patent: July 14, 2015Assignee: ACRUX DDS PTY LTDInventors: Kerrie Setiawan, Adam Watkinson
-
Publication number: 20150094290Abstract: A pharmaceutical composition for transdermal delivery comprising one or more physiologically active agents; one or more dermal penetration enhancers; and a volatile pharmaceutically acceptable carrier comprising a volatile solvent; and wherein the physiologically active agent and dermal penetration enhancer form an amorphous deposit upon evaporation of the volatile carrier, said amorphous deposit forming a reservoir within the stratum corneum; and (A) wherein the composition has a release rate profile of physiologically active agent so as to provide a ratio of the maximum concentration (Cmax) to the average concentration (Cavg) for the physiologically active agent over the dosage interval within the range of 1 to 10.Type: ApplicationFiled: June 16, 2014Publication date: April 2, 2015Applicant: Acrux DDS Pty LtdInventors: Timothy Matthias Morgan, Nina Frances Wilkins, Kathryn Traci-Jane Klose, Barrie Charles Finnin, Barry Leonard Reed
-
Patent number: 8993520Abstract: The invention is directed to a transdermal drug delivery composition which includes at least one physiologically active agent; and at least one volatile solvent; and at least one viscosity modulating agent. The invention extends to methods of administering such a composition to a subject and treatment of subjects using the composition.Type: GrantFiled: June 25, 2010Date of Patent: March 31, 2015Assignee: Acrux DDS Pty LtdInventors: Tony Dipietro, Andrew Humberstone, Igor Gonda, Adam Watkinson, Kerrie Setiawan, Nina Wilkins
-
Publication number: 20150087623Abstract: The invention is directed to a transdermal drug delivery composition which includes at least one physiologically active agent; and at least one volatile solvent; and at least one viscosity modulating agent. The invention extends to methods of administering such a composition to a subject and treatment of subjects using the composition.Type: ApplicationFiled: October 8, 2014Publication date: March 26, 2015Applicant: Acrux DDS Pty LtdInventors: Tony DIPIETRO, Andrew HUMBERSTONE, Igor GONDA, Adam WATKINSON, Kerrie SETIAWAN, Nina WILKINS
-
Publication number: 20150088080Abstract: This invention relates to an implement 1 for applying a volume of liquid to a treatment surface. The implement includes a support means 3 onto which is mounted a receptacle 2, the receptacle defining a reservoir space 4 which receives the liquid. The receptacle includes a wall 6 having a working surface that is used to spread the liquid over the treatment surface. The wall 6 is resiliently deformable so in use the working surface maintains contact with the treatment surface when spreading the liquid. The implement has a specific application in applying a transdermal lotion to the axilla area of the user. The invention also relates to a system for transdermal administration of a physiological active agent from a liquid composition and a method of conducting the same.Type: ApplicationFiled: June 27, 2014Publication date: March 26, 2015Applicant: Acrux DDS Pty LtdInventors: Peter Bayly, Mark Simon Bayly, Magnus Ahlstrom, Adam Charles Watkinson
-
Publication number: 20130316996Abstract: A pharmaceutical composition for transdermal delivery comprising one or more physiologically active agents; one or more dermal penetration enhancers; and a volatile pharmaceutically acceptable carrier comprising a volatile solvent; and wherein the physiologically active agent and dermal penetration enhancer form an amorphous deposit upon evaporation of the volatile carrier, said amorphous deposit forming a reservoir within the stratum corneum; and (A) wherein the composition has a release rate profile of physiologically active agent so as to provide a ratio of the maximum concentration (Cmax) to the average concentration (Cavg) for the physiologically active agent over the dosage interval within the range of 1 to 10.Type: ApplicationFiled: December 11, 2012Publication date: November 28, 2013Applicant: Acrux DDS Pty LtdInventor: Acrux DDS Pty Ltd
-
Publication number: 20130211350Abstract: This invention relates to an implement 1 for applying a volume of liquid to a treatment surface. The implement includes a support means 3 onto which is mounted a receptacle 2, the receptacle defining a reservoir space 4 which receives the liquid. The receptacle includes a wall 6 having a working surface that is used to spread the liquid over the treatment surface. The wall 6 is resiliently deformable so in use the working surface maintains contact with the treatment surface when spreading the liquid. The implement has a specific application in applying a transdermal lotion to the axilla area of the user. The invention also relates to a system for transdermal administration of a physiological active agent from a liquid composition and a method of conducting the same.Type: ApplicationFiled: March 15, 2013Publication date: August 15, 2013Applicant: Acrux DDS Pty LtdInventor: Acrux DDS Pty Ltd
-
Patent number: 7438203Abstract: The invention relates to a method for treatment or prophylaxis of a disease or condition in an animal comprising administering to a mucosal membrane of said animal in need of such treatment a therapeutically effective amount of a drug delivery system comprising at least one physiologically active agent or prodrug thereof and at least one penetration enhancer selected from safe ester sunscreens.Type: GrantFiled: January 20, 2004Date of Patent: October 21, 2008Assignee: Acrux DDS Pty LtdInventors: Barry Lenard Reed, Timothy Matthias Morgan, Barrie Charles Finnin
-
Publication number: 20070293842Abstract: A container includes a receptacle (6) for holding a substance, drug or liquid, and having an opening (7) to the receptacle 6 through which the substance can be dispensed and having a circular and domed spreading surface (15) adjacent the opening for spreading and the accurate delivery of a thin layer of liquid over an area of skin. The container also includes a closure (3) including a cap (4) having a seal or plug (16) for sealing the receptacle (6), and a collar (5) with a cam follower surface (8) rotatable relative to the cap about an axis, whereby rotation of the collar (5) relative to the cap (4) moves the seal in an axial direction away from a seal position.Type: ApplicationFiled: July 14, 2005Publication date: December 20, 2007Applicant: Acrux DDS Pty LtdInventors: Barry Knight, Peter Bayly, Kon Wong, Timothy Morgan
-
Publication number: 20060163276Abstract: A substance dispensing device associated with a usage indicator is disclosed. The device includes a substance storage container and a pump operable to dispense substance from the container. The usage indicator includes a movable member that is movable in response to operation of the pump. The movable member includes an indicator providing a visual indication of the extent to which substance has been dispensed from the device.Type: ApplicationFiled: December 22, 2003Publication date: July 27, 2006Applicant: Acrux DDS Pty LtdInventors: Kon Wong, John Oretti
-
Patent number: 6978945Abstract: Hand-held dispensing devices for dispensing and applying a substance to the skin of a host are described. The devices include a hollow body, a capsule mounted within the hollow body for containing the substance, a nozzle mounted within the hollow body communicating with the substance in the capsule, an actuator to cause metered quantities of the substance to be dispensed from the capsule through the nozzle, a shroud defining an exit space for receiving the substance emerging from the nozzle, and a cap detachably mounted on the shroud to selectively open and close the nozzle and thereby control escape of the substance from the capsule.Type: GrantFiled: May 21, 2003Date of Patent: December 27, 2005Assignee: Acrux DDS Pty LtdInventors: Kon Euan Wong, Mark Simon Bayly
-
Patent number: 6964777Abstract: The present invention provides a transdermal drug delivery system which comprises: a therapeutically effective amount of an antianxiety agent; at least one dermal penetration enhancer, which is a safe skin-tolerant ester sunscreen ester; and at least one volatile liquid. The invention also provides a method for administering at least one systemic acting antianxiety agent to an animal which comprises applying an effective amount of the antianxiety agent in the form of the drug delivery system of the present invention.Type: GrantFiled: May 2, 2003Date of Patent: November 15, 2005Assignee: Acrux DDS PTY LTDInventors: Kathryn Traci-Jane Klose, Ennio La Guardia, Timothy Matthias Morgan, Barrie Charles Finnin, Barry Leonard Reed
-
Patent number: D749225Type: GrantFiled: November 26, 2013Date of Patent: February 9, 2016Assignee: ACRUX DDS PTY LTDInventors: Shu Kuen Chang, Alain Regard, Anastasios G. Karahalios, Mark LaFever
-
Patent number: D750788Type: GrantFiled: November 26, 2013Date of Patent: March 1, 2016Assignee: ACRUX DDS PTY LTDInventors: Shu Kuen Chang, Alain Regard, Anastasios G. Karahalios, Mark LaFever